Last quarter (Q1 2023), Avadel Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q1, Avadel Pharmaceuticals's net income was $-30.78M. See Avadel Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 116.00K	$ 116.00K	$ 0.00	$ 22.33M	$ 59.22M	$ 103.27M
Cost of Revenue	$ 3.35M	$ 3.35M	$ 0.00	$ 5.74M	$ 12.13M	$ 17.52M
Gross Profit	$ -3.35M	$ -3.35M	$ 0.00	$ 16.59M	$ 47.09M	$ 85.75M
Operating Expense	$ 94.89M	$ 95.22M	$ 85.60M	$ 53.25M	$ 63.92M	$ 146.31M
Operating Income	$ -98.23M	$ -98.56M	$ -85.60M	$ -36.66M	$ -16.83M	$ -60.55M
Net Non Operating Interest Income Expense	$ -14.43M	$ -12.88M	$ -9.94M	$ -12.99M	$ -12.48M	$ -10.62M
Other Income Expense	$ -3.05M	$ -203.00K	$ 2.40M	$ 44.57M	$ -9.27M	$ -42.02M
Pretax Income	$ -112.06M	$ -111.44M	$ -93.14M	$ -5.08M	$ -38.58M	$ -113.20M
Tax Provision	$ 29.77M	$ 26.02M	$ -15.82M	$ -12.11M	$ -5.36M	$ -17.89M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -141.82M	$ -137.46M	$ -77.33M	$ 7.03M	$ -33.23M	$ -95.30M
Basic EPS	$ -2.32	$ -2.29	$ -1.32	$ 0.13	$ -0.89	$ -2.55
Diluted EPS	$ -2.32	$ -2.29	$ -1.32	$ 0.13	$ -0.89	$ -2.55
Basic Average Shares	$ 243.22M	$ 60.09M	$ 58.53M	$ 53.00M	$ 37.40M	$ 37.33M
Diluted Average Shares	$ 243.22M	$ 60.09M	$ 58.53M	$ 54.94M	$ 37.40M	$ 37.33M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 98.23M	$ 98.56M	$ 85.60M	$ 58.99M	$ 76.04M	$ 163.82M
Net Income From Continuing And Discontinued Operation	$ -141.82M	$ -137.46M	$ -77.33M	$ 7.03M	$ -33.23M	$ -95.30M
Normalized Income	$ -81.86M	-	$ -79.14M	$ -23.05M	$ -25.24M	$ -59.88M
Interest Expense	$ 7.07M	-	$ 9.94M	$ 12.99M	$ 12.48M	$ 10.62M
EBIT	$ -97.63M	$ -98.56M	$ -83.20M	$ 7.91M	$ -26.10M	$ -102.58M
EBITDA	$ -92.03M	$ -91.02M	$ -82.39M	$ 9.60M	$ -23.61M	$ -95.14M

Currency in USD

Avadel Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing